The US startup Neuralink, which recently implanted one of its chips into the brain of a young quadriplegic man for the first time, has been forced to halt the trial. The company, co-founded by Elon Musk, encountered issues just a few weeks after the operation but has already received FDA approval to find a second test subject. FRANCE 24’s Julia Sieger tells us more.
Source link
Trending
- UNAIDS slams 'unprecedented' disruption to programmes due to US funding cuts
- Australia to face New Zealand at Rugby World Cup as France earn dream draw
- GB Energy aims to attract £15bn funding for renewables
- EU agrees to relax regulations around gene-edited crops – DW – 12/04/2025
- EU proposes using frozen Russian assets to provide €90 billion to Ukeraine
- Spanking tradition ends on German island of Borkum – DW – 12/03/2025
- Brigitte Bardot: The icon who vanished and the film that finds her again
- Matthew Perry’s parents say doctor is ‘among most culpable of all’ ahead of first sentencing over star’s death | Ents & Arts News
